This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| left ventricle | |
|---|---|
| Name | Left ventricle |
| Latin | ventriculus sinister cordis |
| System | Circulatory system |
| Location | Thorax |
| Artery | Left coronary artery; Left anterior descending artery; Circumflex artery |
| Vein | Cardiac veins |
| Nerve | Cardiac plexus |
left ventricle
The left ventricle is a primary cardiac chamber responsible for systemic blood ejection, bounded by the interventricular septum and the mitral and aortic valves. It generates the high pressures required to perfuse the systemic circulation and interacts dynamically with the left atrium, aorta, and pulmonary veins. Structural and functional integrity of the left ventricle is essential in conditions managed by institutions such as Mayo Clinic, Cleveland Clinic, and Johns Hopkins Hospital and is a focus of research at organizations like the American Heart Association and European Society of Cardiology.
The chamber's gross anatomy includes the thick myocardial wall, trabeculated apex, smooth outflow tract, and fibrous annuli of the mitral and aortic valves. Anatomical landmarks used in imaging and surgery reference structures named after eponyms and places, including the His bundle, Purkinje fibers, and the interventricular septum. Surgical approaches reference techniques from centers like Mount Sinai Hospital and Massachusetts General Hospital and draw upon atlases by authors affiliated with Oxford University Press and Cambridge University Press. Internal architecture is described in texts associated with Gray's Anatomy and curricula at Harvard Medical School, Stanford University School of Medicine, and University College London.
The left ventricle converts myocardial contraction into stroke volume and cardiac output via coordinated excitation–contraction coupling regulated by ion channels and autonomic inputs. Hemodynamic performance is described in studies from World Health Organization collaborations and trials funded by agencies such as the National Institutes of Health and Wellcome Trust. Physiologic parameters—ejection fraction, end-diastolic volume, and pressure–volume loops—are central to guidelines from European Society of Cardiology and American College of Cardiology and to trials like those conducted by Cardiothoracic Surgical Trials Network.
Coronary perfusion of the left ventricle is principally via the left coronary artery, subdividing into the left anterior descending artery and the circumflex artery; collateral patterns and dominance are described in angiographic series from Cleveland Clinic and Mayo Clinic. Venous drainage proceeds through the great cardiac vein into the coronary sinus, studied in operative series at Johns Hopkins Hospital and Toronto General Hospital. Autonomic innervation arises from the cardiac plexus with sympathetic fibers from thoracic ganglia and parasympathetic fibers mediated via the vagus nerve, topics elaborated in monographs published by Elsevier and lecture series at Johns Hopkins School of Medicine.
Embryologic morphogenesis of the left ventricle involves cardiac looping, chamber specification, and septation driven by genetic regulators and signaling pathways investigated in laboratories at Harvard Medical School, MIT, and the Salk Institute. Key molecular players have been characterized in studies associated with awards such as the Lasker Award and include transcription factors and growth factors identified in consortia linked to the National Institutes of Health. Congenital malformations are catalogued in registries maintained by centers including Great Ormond Street Hospital and Boston Children's Hospital.
Pathologies affecting the left ventricle span ischemic injury from coronary artery disease, pressure overload from aortic stenosis, volume overload from valvular regurgitation, cardiomyopathies, and arrhythmogenic substrates implicated in sudden cardiac death. Landmark trials and registries—conducted by organizations such as the American Heart Association, European Society of Cardiology, and National Heart, Lung, and Blood Institute—inform management of heart failure, myocardial infarction, and hypertrophic cardiomyopathy. Device therapies and interventions developed at centers like Cleveland Clinic and companies reviewed by regulators such as the U.S. Food and Drug Administration target left ventricular dysfunction.
Assessment employs imaging and invasive modalities standardized by professional bodies including the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Transthoracic and transesophageal echocardiography, cardiac magnetic resonance imaging pioneered in studies from Mayo Clinic and Johns Hopkins Hospital, computed tomography angiography in protocols from Society of Cardiovascular Computed Tomography, and invasive coronary angiography used in trials by the Cardiothoracic Surgical Trials Network quantify structure and function. Biomarkers and electrophysiologic studies guided by recommendations from the American College of Cardiology and Heart Rhythm Society complement imaging in diagnostic algorithms.
Medical, interventional, and surgical strategies follow evidence from randomized controlled trials supported by bodies such as the National Institutes of Health and implemented at centers including Cleveland Clinic and Mayo Clinic. Pharmacotherapies include agents endorsed in guidelines from the American College of Cardiology and European Society of Cardiology. Revascularization via percutaneous coronary intervention or coronary artery bypass grafting, valve repair or replacement, ventricular assist devices developed with industry partners and regulated by the U.S. Food and Drug Administration, and heart transplantation performed at institutions like Cleveland Clinic and Cleveland Clinic Foundation address left ventricular failure. Multidisciplinary cardiac rehabilitation programs modeled on protocols from World Health Organization initiatives support recovery and secondary prevention.